HEP-50768, a potent and selective inverse agonist of MRGPRX4, suppresses bile-acid-induced pruritic behaviors in humanized rats, indicating its potential for cholestatic itch treatment.
- 1 cites
Moving in bioRxiv, Cellular & molecular immunology, Environmental pollution, mSystems, Nature Chemical Biology and Stem cell research.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
HEP-50768, a potent and selective inverse agonist of MRGPRX4, suppresses bile-acid-induced pruritic behaviors in humanized rats, indicating its potential for cholestatic itch treatment.
Restoring IL-17D in glioblastoma reprograms CD93(+) antigen-presenting cells, extending survival by activating immune responses in mouse models.
Journals this month
Topics moving, week to 23 Oct 2026